Growing community of inventors

Leiden, Netherlands

Peter Christian De Visser

Average Co-Inventor Count = 2.27

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 29

Peter Christian De VisserJudith Christina Theodora Van Deutekom (2 patents)Peter Christian De VisserSusan Allegonda Maria Mulders (2 patents)Peter Christian De VisserPeter Abraham Christiaan 't Hoen (1 patent)Peter Christian De VisserAdriana Marie Aartsma-Rus (1 patent)Peter Christian De VisserSilvana Maria Gerarda Jirka (1 patent)Peter Christian De VisserMaria Begoña Aguilera Diez (1 patent)Peter Christian De VisserPeter Abraham Christiaan 'T Hoen (0 patent)Peter Christian De VisserPeter Christian De Visser (5 patents)Judith Christina Theodora Van DeutekomJudith Christina Theodora Van Deutekom (23 patents)Susan Allegonda Maria MuldersSusan Allegonda Maria Mulders (2 patents)Peter Abraham Christiaan 't HoenPeter Abraham Christiaan 't Hoen (2 patents)Adriana Marie Aartsma-RusAdriana Marie Aartsma-Rus (1 patent)Silvana Maria Gerarda JirkaSilvana Maria Gerarda Jirka (1 patent)Maria Begoña Aguilera DiezMaria Begoña Aguilera Diez (1 patent)Peter Abraham Christiaan 'T HoenPeter Abraham Christiaan 'T Hoen (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Biomarin Technologies B.v. (3 from 16 patents)

2. Academisch Ziekenhuis Leiden (1 from 47 patents)

3. Vico Therapeutics B.v. (1 from 2 patents)


5 patents:

1. 11459358 - Substances for targeting various selected organs or tissues

2. 11345915 - RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

3. 10913946 - RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy

4. 10179912 - RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

5. 9745576 - RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…